It is also known that p53 expression dampens the senescence-associated secretory response [57], suggesting that AD-induced p53 downregulation may be responsible for elevating levels of inflammatory cytokines such as IL-8 that, in turn, promote prostate cancer progression [58], [59]. Here, TP53 is linked to prostate cancer.